MEDROXYPROGESTERONE ACETATE

Generic: MEDROXYPROGESTERONE ACETATE

Amphastar PharmaceuticalsManufacturer
INTRAMUSCULARRoute
MEDROXYPROGESTERONE ACETATEActive Substance
2017-11-28Original Approval

MEDROXYPROGESTERONE ACETATE is FDA application ANDA077334, sponsored by AMPHASTAR PHARMS INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
BREAST CANCER FEMALE
2,993 reports
2
BREAST CANCER
1,819 reports
3
MENINGIOMA
844 reports
4
BREAST CANCER METASTATIC
434 reports
5
DRUG INEFFECTIVE
309 reports
6
OFF LABEL USE
234 reports
7
OESTROGEN RECEPTOR ASSAY POSITIVE
215 reports
8
PAIN
200 reports
9
OVARIAN CANCER
186 reports
10
NAUSEA
182 reports